Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Prima BioMed Ltd (IMMP) had Return on Tangible Equity of -45.03% for the most recently reported fiscal year, ending 2025-06-30.
| Income Statement Financials | |
$6.69M |
|
$-39.78M |
|
-- |
|
$6.69M |
|
$45.39M |
|
$-38.70M |
|
$-1.08M |
|
$-39.78M |
|
$-39.78M |
|
$-39.78M |
|
$-39.78M |
|
$-39.78M |
|
$-39.78M |
|
$-38.70M |
|
$-37.15M |
|
145.58M |
|
145.58M |
|
$-0.27 |
|
$-0.27 |
|
| Balance Sheet Financials | |
$96.56M |
|
$0.04M |
|
$5.11M |
|
$101.66M |
|
$8.26M |
|
-- |
|
$0.38M |
|
$8.64M |
|
$93.02M |
|
$88.36M |
|
$93.02M |
|
146.04M |
|
| Cash Flow Statement Financials | |
$-40.18M |
|
$-24.95M |
|
$-0.34M |
|
$104.78M |
|
$43.65M |
|
$-61.12M |
|
$0.75M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.69 |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
100.00% |
|
-578.44% |
|
-578.44% |
|
-555.31% |
|
-594.64% |
|
-594.64% |
|
$-40.21M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
1.05 |
|
348.64 |
|
-42.77% |
|
|
Return on Tangible Equity |
-45.03% |
-39.13% |
|
-42.77% |
|
$0.64 |
|
$-0.28 |
|
$-0.28 |
|